Chuang J - Search Results

1

Moving Beyond Conventional Clinical Trial End Points in Treatment-refractory Metastatic Colorectal Cancer: A Composite Quality-of-life and Symptom Control End Point.

Gong J, Wu D, Chuang J, Tuli R, Simard J, Hendifar A. Gong J, et al. Among authors: chuang j. Clin Ther. 2017 Nov;39(11):2135-2145. doi: 10.1016/j.clinthera.2017.09.015. Epub 2017 Oct 25. Clin Ther. 2017. PMID: 29079389 Review.

2

Combination systemic therapies with immune checkpoint inhibitors in pancreatic cancer: overcoming resistance to single-agent checkpoint blockade.

Gong J, Hendifar A, Tuli R, Chuang J, Cho M, Chung V, Li D, Salgia R. Gong J, et al. Among authors: chuang j. Clin Transl Med. 2018 Oct 8;7(1):32. doi: 10.1186/s40169-018-0210-9. Clin Transl Med. 2018. PMID: 30294755 Free PMC article. Review.

3

Checkpoint inhibition in advanced gastroesophageal cancer: clinical trial data, molecular subtyping, predictive biomarkers, and the potential of combination therapies.

Chuang J, Chao J, Hendifar A, Klempner SJ, Gong J. Chuang J, et al. Transl Gastroenterol Hepatol. 2019 Aug 27;4:63. doi: 10.21037/tgh.2019.08.04. eCollection 2019. Transl Gastroenterol Hepatol. 2019. PMID: 31559344 Free PMC article. Review.

4

Molecular Targets, Pathways, and Therapeutic Implications for Hepatocellular Carcinoma.

Gong J, Chuang J, Cho M, Toomey K, Hendifar A, Li D. Gong J, et al. Among authors: chuang j. Int J Mol Sci. 2020 Jul 23;21(15):5232. doi: 10.3390/ijms21155232. Int J Mol Sci. 2020. PMID: 32718047 Free PMC article. Review.

5

A Phase I Clinical Trial of Trametinib in Combination with TAS-102 in Patients with Chemotherapy-Resistant RAS-Mutated (PIK3CA/PTEN-Wild Type) Metastatic Colorectal Cancer.

Chuang J, Gong J, Li SM, Wang C, Fakih M. Chuang J, et al. Clin Colorectal Cancer. 2022 Sep;21(3):252-258. doi: 10.1016/j.clcc.2022.05.004. Epub 2022 May 23. Clin Colorectal Cancer. 2022. PMID: 35738999 Clinical Trial.

6

Refining the management of resectable esophagogastric cancer: FLOT4, CRITICS, OE05, MAGIC-B and the promise of molecular classification.

Chuang J, Gong J, Klempner SJ, Woo Y, Chao J. Chuang J, et al. J Gastrointest Oncol. 2018 Jun;9(3):560-572. doi: 10.21037/jgo.2018.03.01. J Gastrointest Oncol. 2018. PMID: 29998022 Free PMC article. Review.

7

Therapeutic Advances and Challenges in the Management of HER2-Positive Gastroesophageal Cancers.

Chuang J, Klempner S, Waters K, Atkins K, Chao J, Cho M, Hendifar A, Gangi A, Burch M, Mehta P, Gong J. Chuang J, et al. Diseases. 2022 Apr 19;10(2):23. doi: 10.3390/diseases10020023. Diseases. 2022. PMID: 35645244 Free PMC article. Review.

8

MAP2K1 Mutations in Advanced Colorectal Cancer Predict Poor Response to Anti-EGFR Therapy and to Vertical Targeting of MAPK Pathway.

Chuang J, Wang C, Guo Y, Valenzuela V, Wu J, Fakih M. Chuang J, et al. Clin Colorectal Cancer. 2021 Mar;20(1):72-78. doi: 10.1016/j.clcc.2020.12.003. Epub 2020 Dec 17. Clin Colorectal Cancer. 2021. PMID: 33436306

9

Locally advanced anal small cell carcinoma with durable complete response to chemoradiation followed by consolidation chemotherapy: case report and literature review.

Chuang J, Wang C, Parekh V, Fakih M. Chuang J, et al. J Gastrointest Oncol. 2021 Dec;12(6):3148-3154. doi: 10.21037/jgo-21-434. J Gastrointest Oncol. 2021. PMID: 35070438 Free PMC article.

10

Fulminant Disseminated Intravascular Coagulation as Initial Presentation of BRAF-Mutated Melanoma.

Chuang J, Uche A, Gupta R, Margolin K, Kim P. Chuang J, et al. Case Rep Oncol Med. 2019 Apr 9;2019:9246596. doi: 10.1155/2019/9246596. eCollection 2019. Case Rep Oncol Med. 2019. PMID: 31093395 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,156 results

Search Page

Filters